treatment resistant major depressive disorder
Showing 1 - 7 of 7
Treatment Resistant MDD Trial (Psychotherapy, Treatment as Usual, Intranasal Ketamine (esketamine))
Recruiting
- Treatment Resistant Major Depressive Disorder
- Psychotherapy
- +2 more
-
Edmonton, Alberta, CanadaCity Center Pharmacy and Medical Clinic
Nov 9, 2022
Treatment Resistant MDD Trial (Almond Therapy, Intranasal ketamine (Esketamine), Treatment as Usual)
Not yet recruiting
- Treatment Resistant Major Depressive Disorder
- Almond Therapy
- +2 more
- (no location specified)
Jun 24, 2022
Treatment Resistant MDD Trial in Canada, United States (Aripiprazole, Repetitive transcranial magnetic stimulation (rTMS),
Completed
- Treatment Resistant Major Depressive Disorder
- Aripiprazole
- +2 more
-
Birmingham, Alabama
- +12 more
Apr 26, 2022
Treatment Resistant MDD Trial in Houston (Activa Tremor Control Sys (DBS Implant), Randomized, staggered withdrawal phase)
Active, not recruiting
- Treatment Resistant Major Depressive Disorder
- Activa Tremor Control Sys (DBS Implant)
- Randomized, staggered withdrawal phase
-
Houston, TexasBaylor College of Medicine
Oct 28, 2021
Treatment Resistant MDD Trial in Shanghai (Bilateral surgical implantation of DBS system to Habeluna, Follow-up Period)
Terminated
- Treatment Resistant Major Depressive Disorder
- Bilateral surgical implantation of DBS system to Habeluna
- Follow-up Period
-
Shanghai, Shanghai, China
- +1 more
Nov 26, 2019
Treatment Resistant MDD Trial run by the (AZD6765, Placebo to AZD6765)
Completed
- Treatment Resistant Major Depressive Disorder
- AZD6765
- Placebo to AZD6765
-
Bethesda, MarylandResearch Site
Oct 15, 2014